This is an observational study describing the real-life antipsychotic treatment during the hospitalisation of the patients due to acute psychotic episode. In this NIS subject's data will be collected at one visit at the moment of discharge from the hospital. The results of the study would help to characterise the discrepancy between current clinical practice and treatment guidelines, indicating that atypical antipsychotics are preferable and should be used in monotherapy during acute psychotic episodes in subjects with schizophrenia. Available evidence have revealed a frequent use of first-generation antipsychotics, polypharmacy, intramuscular route of administration and use of atypical antipsychotics in doses lower than recommended in registered summary of product characteristics.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Description of used atypical antipsychotic(s) during hospitalisation
Timeframe: hospitalisation period, an expected average of 2 weeks (variable per patient)
Description of the daily dosage of atypical antipsychotic(s) during hospitalisation
Timeframe: hospitalisation period, an expected average of 2 weeks (variable per patient)
Description of mode of administration of atypical antipsychotic(s) during hospitalisation
Timeframe: hospitalisation period, an expected average of 2 weeks (variable per patient)